Header Logo

MUSTAFA OZEN

TitleAdjunct Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pathology & Immunology
AddressDepartment of Pathology
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Karaca Dogan B, Salman Yilmaz S, Izgi GN, Ozen M. Circulating non-coding RNAs as a tool for liquid biopsy in solid tumors. Epigenomics. 2025 Apr; 17(5):335-358. PMID: 40040488; PMCID: PMC11970797.
      Citations: 2     Fields:    Translation:Humans
    2. Usta Saglam NG, Duz MB, Salman Yilmaz S, Ozen M, Balcioglu I. Comparison of microRNA expression levels in patients with schizophrenia before and after electroconvulsive therapy. Psychiatr Genet. 2024 Aug 01; 34(4):79-85. PMID: 38842000.
      Citations:    Fields:    Translation:Humans
    3. Baniahmad A, Ozen M. Editorial: Epigenetics in prostate cancer. Front Oncol. 2023; 13:1268519. PMID: 38023204; PMCID: PMC10661226.
      Citations:    
    4. Boyukozer FB, Tanoglu EG, Ozen M, Ittmann M, Aslan ES. Kallikrein gene family as biomarkers for recurrent prostate cancer. Croat Med J. 2020 Oct 31; 61(5):450-456. PMID: 33150763; PMCID: PMC7684543.
      Citations: 2     Fields:    Translation:Humans
    5. Ozen M, Lipniacki T, Levchenko A, Emamian ES, Abdi A. Modeling and measurement of signaling outcomes affecting decision making in noisy intracellular networks using machine learning methods. Integr Biol (Camb). 2020 05 21; 12(5):122-138. PMID: 32424393; PMCID: PMC7240334.
      Citations:    
    6. Koparir A, Karatas OF, Yilmaz SS, Suer I, Ozer B, Yuceturk B, Ozen M. Revealing the functions of novel mutations in RAB3GAP1 in Martsolf and Warburg micro syndromes. Am J Med Genet A. 2019 04; 179(4):579-587. PMID: 30730599.
      Citations: 3     Fields:    Translation:HumansCells
    7. Suer I, Guzel E, Karatas OF, Creighton CJ, Ittmann M, Ozen M. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271. PMID: 30345533.
      Citations: 12     Fields:    Translation:Humans
    8. Karatas OF, Wang J, Shao L, Ozen M, Zhang Y, Creighton CJ, Ittmann M. miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer. Oncotarget. 2017 Sep 01; 8(36):60243-60256. PMID: 28947967; PMCID: PMC5601135.
      Citations: 16     Fields:    
    9. Pashaei E, Pashaei E, Ahmady M, Ozen M, Aydin N. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy. PLoS One. 2017; 12(6):e0179543. PMID: 28651018; PMCID: PMC5484492.
      Citations: 60     Fields:    Translation:Humans
    10. Karatas OF, Suer I, Yuceturk B, Yilmaz M, Oz B, Guven G, Cansiz H, Creighton CJ, Ittmann M, Ozen M. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer. 2016 11 05; 16(1):853. PMID: 27816053; PMCID: PMC5097853.
      Citations: 6     Fields:    Translation:HumansCells
    11. Pashaei E, Guzel E, Ozgurses ME, Demirel G, Aydin N, Ozen M. A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets. PLoS One. 2016; 11(9):e0161491. PMID: 27655328; PMCID: PMC5031439.
      Citations: 10     Fields:    
    12. Elagoz Yuksel M, Yuceturk B, Karatas OF, Ozen M, Dogangun B. The altered promoter methylation of oxytocin receptor gene in autism. J Neurogenet. 2016 Sep - Dec; 30(3-4):280-284. PMID: 27309964.
      Citations: 20     Fields:    Translation:HumansCells
    13. Karatas OF, Guzel E, Duz MB, Ittmann M, Ozen M. The role of ATP-binding cassette transporter genes in the progression of prostate cancer. Prostate. 2016 Apr; 76(5):434-44. PMID: 26708806.
      Citations: 15     Fields:    Translation:Humans
    14. Duz MB, Karatas OF, Guzel E, Turgut NF, Yilmaz M, Creighton CJ, Ozen M. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol (Dordr). 2016 Apr; 39(2):187-93. PMID: 26650483.
      Citations: 34     Fields:    Translation:Humans
    15. Coskun BD, Altinkaya E, Sevinc E, Ozen M, Karaman H, Karaman A, Poyrazoglu O. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients. Rev Esp Enferm Dig. 2015 Dec; 107(12):740-4. PMID: 26671586.
      Citations:    
    16. Lee B, Duz MB, Sagong B, Koparir A, Lee KY, Choi JY, Seven M, Yuksel A, Kim UK, Ozen M. Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome. Gene. 2016 Feb 01; 576(2 Pt 2):776-81. PMID: 26551301.
      Citations: 2     Fields:    Translation:HumansCells
    17. Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, Gonzaga-Jauregui C, Erdin S, Bayram Y, Campbell IM, Hunter JV, Atik MM, Van Esch H, Yuan B, Wiszniewski W, Isikay S, Yesil G, Yuregir OO, Tug Bozdogan S, Aslan H, Aydin H, Tos T, Aksoy A, De Vivo DC, Jain P, Geckinli BB, Sezer O, Gul D, Durmaz B, Cogulu O, Ozkinay F, Topcu V, Candan S, Cebi AH, Ikbal M, Yilmaz Gulec E, Gezdirici A, Koparir E, Ekici F, Coskun S, Cicek S, Karaer K, Koparir A, Duz MB, Kirat E, Fenercioglu E, Ulucan H, Seven M, Guran T, Elcioglu N, Yildirim MS, Aktas D, Alikasifoglu M, Ture M, Yakut T, Overton JD, Yuksel A, Ozen M, Muzny DM, Adams DR, Boerwinkle E, Chung WK, Gibbs RA, Lupski JR. Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease. Neuron. 2015 Nov 04; 88(3):499-513. PMID: 26539891; PMCID: PMC4824012.
      Citations: 111     Fields:    Translation:Humans
    18. Karatas OF, Suer I, Yuceturk B, Yilmaz M, Hajiyev Y, Creighton CJ, Ittmann M, Ozen M. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2016 Mar; 37(3):4183-92. PMID: 26490990.
      Citations: 14     Fields:    Translation:HumansCells
    19. Atik T, Koparir A, Bademci G, Foster J, Altunoglu U, Bowdin S, Elcioglu N, Tayfun GA, Atik SS, Ozen M, Ozkinay F, Alanay Y, Kayserili H, Thiel S, Tekin M, Mutlu GY. Novel MASP1 mutations are associated with an expanded phenotype in 3MC1 syndrome. Orphanet J Rare Dis. 2015 Sep 30; 10:128. PMID: 26419238; PMCID: PMC4589207.
      Citations: 15     Fields:    Translation:Humans
    20. Koparir A, Karatas OF, Yuceturk B, Yuksel B, Bayrak AO, Gerdan OF, Sagiroglu MS, Gezdirici A, Kirimtay K, Selcuk E, Karabay A, Creighton CJ, Yuksel A, Ozen M. Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis. Hum Mol Genet. 2015 Oct 01; 24(19):5378-87. PMID: 26162852.
      Citations: 11     Fields:    Translation:HumansCells
    21. Karatas OF, Yuceturk B, Suer I, Yilmaz M, Cansiz H, Solak M, Ittmann M, Ozen M. Role of miR-145 in human laryngeal squamous cell carcinoma. Head Neck. 2016 Feb; 38(2):260-6. PMID: 26083661.
      Citations: 16     Fields:    Translation:HumansCells
    22. Ozen M, Karatas OF, Gulluoglu S, Bayrak OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ, Ittmann M. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest. 2015 Jul; 33(6):251-8. PMID: 25951106.
      Citations: 44     Fields:    Translation:HumansCells
    23. Yilmaz SS, Guzel E, Karatas OF, Yilmaz M, Creighton CJ, Ozen M. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope. 2015 Dec; 125(12):E377-81. PMID: 25945817.
      Citations: 12     Fields:    Translation:Humans
    24. Cengiz M, Karatas OF, Koparir E, Yavuzer S, Ali C, Yavuzer H, Kirat E, Karter Y, Ozen M. Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore). 2015 Apr; 94(13):e693. PMID: 25837765; PMCID: PMC4554020.
      Citations: 22     Fields:    Translation:HumansCells
    25. Koparir A, Karatas OF, Atayoglu AT, Yuksel B, Sagiroglu MS, Seven M, Ulucan H, Yuksel A, Ozen M. Whole-exome sequencing revealed two novel mutations in Usher syndrome. Gene. 2015 Jun 01; 563(2):215-8. PMID: 25834954.
      Citations: 1     Fields:    Translation:Humans
    26. Yuan B, Pehlivan D, Karaca E, Patel N, Charng WL, Gambin T, Gonzaga-Jauregui C, Sutton VR, Yesil G, Bozdogan ST, Tos T, Koparir A, Koparir E, Beck CR, Gu S, Aslan H, Yuregir OO, Al Rubeaan K, Alnaqeb D, Alshammari MJ, Bayram Y, Atik MM, Aydin H, Geckinli BB, Seven M, Ulucan H, Fenercioglu E, Ozen M, Jhangiani S, Muzny DM, Boerwinkle E, Tuysuz B, Alkuraya FS, Gibbs RA, Lupski JR. Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. J Clin Invest. 2015 Feb; 125(2):636-51. PMID: 25574841; PMCID: PMC4319410.
      Citations: 72     Fields:    Translation:HumansCellsCTClinical Trials
    27. Ekin A, Karatas OF, Culha M, Ozen M. Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells. J Gene Med. 2014 Nov-Dec; 16(11-12):331-5. PMID: 25331590.
      Citations: 32     Fields:    Translation:HumansCells
    28. Guzel E, Karatas OF, Duz MB, Solak M, Ittmann M, Ozen M. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer. Prostate. 2014 Nov; 74(15):1498-505. PMID: 25175483.
      Citations: 23     Fields:    Translation:HumansCells
    29. Yilmaz M, Karatas OF, Yuceturk B, Dag H, Yener M, Ozen M. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues. Head Neck. 2015 Sep; 37(9):1344-8. PMID: 24817638.
      Citations: 14     Fields:    Translation:Humans
    30. Koparir A, Gezdirici A, Koparir E, Ulucan H, Yilmaz M, Erdemir A, Yuksel A, Ozen M. Poikiloderma with neutropenia: genotype-ethnic origin correlation, expanding phenotype and literature review. Am J Med Genet A. 2014 Oct; 164A(10):2535-40. PMID: 25044170.
      Citations: 6     Fields:    Translation:Humans
    31. Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, Creighton CJ, Ittmann M, Ozen M. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9. PMID: 24976077.
      Citations: 25     Fields:    Translation:HumansCells
    32. Karatas OF, Guzel E, Suer I, Ekici ID, Caskurlu T, Creighton CJ, Ittmann M, Ozen M. miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One. 2014; 9(6):e98675. PMID: 24967583; PMCID: PMC4072786.
      Citations: 44     Fields:    Translation:HumansCells
    33. Seven M, Karatas OF, Duz MB, Ozen M. The role of miRNAs in cancer: from pathogenesis to therapeutic implications. Future Oncol. 2014 May; 10(6):1027-48. PMID: 24941988.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    34. Karaca E, Weitzer S, Pehlivan D, Shiraishi H, Gogakos T, Hanada T, Jhangiani SN, Wiszniewski W, Withers M, Campbell IM, Erdin S, Isikay S, Franco LM, Gonzaga-Jauregui C, Gambin T, Gelowani V, Hunter JV, Yesil G, Koparir E, Yilmaz S, Brown M, Briskin D, Hafner M, Morozov P, Farazi TA, Bernreuther C, Glatzel M, Trattnig S, Friske J, Kronnerwetter C, Bainbridge MN, Gezdirici A, Seven M, Muzny DM, Boerwinkle E, Ozen M, Baylor Hopkins Center for Mendelian Genomics, Clausen T, Tuschl T, Yuksel A, Hess A, Gibbs RA, Martinez J, Penninger JM, Lupski JR. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell. 2014 Apr 24; 157(3):636-50. PMID: 24766809; PMCID: PMC4146440.
      Citations: 104     Fields:    Translation:HumansAnimalsCells
    35. Suer I, Karatas OF, Yuceturk B, Yilmaz M, Guven G, Buge O, Cansiz H, Ozen M. Characterization of stem-like cells directly isolated from freshly resected laryngeal squamous cell carcinoma specimens. Curr Stem Cell Res Ther. 2014; 9(4):347-53. PMID: 24678693.
      Citations: 6     Fields:    Translation:HumansCells
    36. Bayrak OF, Gulluoglu S, Aydemir E, Ture U, Acar H, Atalay B, Demir Z, Sevli S, Creighton CJ, Ittmann M, Sahin F, Ozen M. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol. 2013 Nov; 115(2):143-51. PMID: 23912551.
      Citations: 28     Fields:    Translation:HumansCells
    37. Seven M, Gezdirici A, Ulucan H, Karatas OF, Yosunkaya E, Yuksel A, Ozen M. A novel EFNB1 mutation in a patient with craniofrontonasal syndrome and right hallux duplication. Gene. 2013 Sep 25; 527(2):675-8. PMID: 23845783.
      Citations: 1     Fields:    Translation:Humans
    38. Karatas OF, Guzel E, Karaca E, Sevli S, Soyucen E, Yuksel A, Ozen M. MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients. Mol Biol Rep. 2013 Jul; 40(7):4619-23. PMID: 23649765.
      Citations: 2     Fields:    Translation:HumansCells
    39. Ulucan H, Koparir E, Koparir A, Karaca E, Emre R, Gezdirici A, Yosunkaya E, Seven M, Ozen M, Yuksel A. Circumferential skin folds and multiple anomalies: confirmation of a distinct autosomal recessive Michelin tire baby syndrome. Clin Dysmorphol. 2013 Apr; 22(2):87-90. PMID: 23324645.
      Citations: 4     Fields:    Translation:Humans
    40. Gezdirici A, Yenigun A, Koparir E, Yosunkaya E, Ulucan H, Seven M, Yuksel A, Ozen M. A rare case of split hand/foot malformation with sensorineural hearing loss and Mondini dysplasia. Clin Dysmorphol. 2013 Jan; 22(1):33-5. PMID: 23168687.
      Citations:    Fields:    Translation:Humans
    41. Karaca E, Karakoc-Aydiner E, Bayrak OF, Keles S, Sevli S, Barlan IB, Yuksel A, Chatila TA, Ozen M. Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder. Gene. 2013 Jan 10; 512(2):189-93. PMID: 23124046.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    42. Aydemir E, Bayrak OF, Sahin F, Atalay B, Kose GT, Ozen M, Sevli S, Dalan AB, Yalvac ME, Dogruluk T, T?re U. Characterization of cancer stem-like cells in chordoma. J Neurosurg. 2012 Apr; 116(4):810-20. PMID: 22283189.
      Citations: 22     Fields:    Translation:HumansCells
    43. Bayrak OF, Aydemir E, Gulluoglu S, Sahin F, Sevli S, Yalvac ME, Acar H, Ozen M. The effects of chemotherapeutic agents on differentiated chordoma cells. J Neurosurg Spine. 2011 Dec; 15(6):620-4. PMID: 21905773.
      Citations: 3     Fields:    Translation:HumansCells
    44. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, Ittmann M. Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res. 2009 Jun 15; 15(12):3979-89. PMID: 19509179; PMCID: PMC2734921.
      Citations: 79     Fields:    Translation:HumansCells
    45. Castro P, Creighton CJ, Ozen M, Berel D, Mims MP, Ittmann M. Genomic profiling of prostate cancers from African American men. Neoplasia. 2009 Mar; 11(3):305-12. PMID: 19242612; PMCID: PMC2647733.
      Citations: 24     Fields:    Translation:Humans
    46. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008 Mar 13; 27(12):1788-93. PMID: 17891175.
      Citations: 317     Fields:    Translation:HumansCells
    47. Shafer J, Davis AR, Gannon FH, Fouletier-Dilling CM, Lazard Z, Moran K, Gugala Z, Ozen M, Ittmann M, Heggeness MH, Olmsted-Davis E. Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation. Tissue Eng. 2007 Aug; 13(8):2011-9. PMID: 17518751.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    48. Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007 Feb; 170(2):620-32. PMID: 17255330; PMCID: PMC1851874.
      Citations: 64     Fields:    Translation:HumansAnimalsCells
    49. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res. 2006 Nov 15; 66(22):11039-46. PMID: 17108143.
      Citations: 63     Fields:    Translation:HumansAnimalsCells
    50. Dai H, Li R, Wheeler T, Ozen M, Ittmann M, Anderson M, Wang Y, Rowley D, Younes M, Ayala GE. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol. 2007 Feb; 38(2):299-307. PMID: 17097719.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    51. Ozen M, Ittmann M. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer. Clin Cancer Res. 2005 Jul 01; 11(13):4701-6. PMID: 16000564.
      Citations: 33     Fields:    Translation:HumansCells
    52. Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer. 2004 Dec; 11(4):709-24. PMID: 15613447.
      Citations: 129     Fields:    Translation:HumansCells
    53. Ozen M, Medrano EE, Ittmann M. Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor. Melanoma Res. 2004 Feb; 14(1):13-21. PMID: 15091189.
      Citations: 11     Fields:    Translation:HumansCells
    54. Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, Rosen JM, Ittmann M, Greenberg NM, Spencer DM. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res. 2003 Oct 01; 63(19):6237-43. PMID: 14559809.
      Citations: 32     Fields:    Translation:AnimalsCells
    55. Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res. 2003 Sep 15; 63(18):5754-60. PMID: 14522896.
      Citations: 42     Fields:    Translation:AnimalsCells
    56. Ozen M, Giri D, Ropiquet F, Mansukhani A, Ittmann M. Role of fibroblast growth factor receptor signaling in prostate cancer cell survival. J Natl Cancer Inst. 2001 Dec 05; 93(23):1783-90. PMID: 11734594.
      Citations: 26     Fields:    Translation:HumansCells
    57. Giri D, Ozen M, Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol. 2001 Dec; 159(6):2159-65. PMID: 11733366; PMCID: PMC1850613.
      Citations: 102     Fields:    Translation:HumansCells
    58. Ozen M, Multani A, Chang S, Voneschenbach A, Chung L, Pathak S. Establishment of an in vitro cell model system to study human prostate carcinogenesis. Int J Oncol. 1996 May; 8(5):883-8. PMID: 21544441.
      Citations: 2     Fields:    
    OZEN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (356)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _